Akero Therapeutics, Inc. Total Assets
Akero Therapeutics, Inc. had Total Assets of $1.01 billion as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-11-07
- 2025-09-30: Assets $1.01B.
- 2025-06-30: Assets $1.11B.
- 2025-03-31: Assets $1.16B.
- 2024-12-31: Assets $825.89M.
| Period end | Assets |
|---|---|
| 2025-09-30 | $1.01B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.11B 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.16B 10-Q · filed 2025-05-12 |
| 2024-12-31 | $825.89M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $817.55M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $865.04M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $912.24M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $580.27M 10-K · filed 2025-02-28 |
| 2023-09-30 | $635.33M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $663.81M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $348.82M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $356.57M 10-K · filed 2024-02-29 |
| 2022-09-30 | $379.41M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $185.68M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $169.89M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $195.55M 10-K · filed 2023-03-17 |
| 2021-09-30 | $223.53M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $238.01M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $257.62M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $273.34M 10-K · filed 2022-02-25 |
| 2020-09-30 | $300.04M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $114.06M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $126.62M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $138.12M 10-K · filed 2021-03-16 |
| 2019-09-30 | $150.14M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $163.17M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $77.15M 10-K · filed 2020-03-16 |